Acquired elliptocytosis of myelodysplastic syndrome.
نویسندگان
چکیده
A 75-year-old man with a 5-year history of myelodysplastic syndrome (MDS) subsequently developed worsening fatigue, dizziness, and dyspnea on exertion. There was no family history of hematologic diseases. On examination he was cachectic with no hepatosplenomegaly and petechiae, but purpuric lesions were present on his hands. The complete blood count showed pancytopenia (hemoglobin 10.2 g/dL, white blood cell count 2.8 k/uL, absolute neutrophil count 1.6 k/uL, platelets 23 k/uL) with a mean corpuscular volume of 101.3 fL. Reticulocyte count was not performed. The peripheral smear showed striking elliptocytosis (see figure). Bone marrow biopsy revealed hypercellularity with prominent megakaryocytic and granulocytic dysplastic. Conventional cytogenetic analysis detected a del(20)(q11.2) with a sideline showing a marker chromosome. The earlier hematologic assessment 5 years prior showed an isolated del(20q)(q11.2) with no evidence of elliptocytosis.
منابع مشابه
Acquired Elliptocytosis as a Manifestation of Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia
Acquired elliptocytosis is a known but rarely described abnormality in the myelodysplastic syndromes (MDS). Here we report the case of an elderly male who was admitted to the hospital with chest pain, dyspnea, and fatigue and was found to be anemic with an elliptocytosis that had only recently been noted on peripheral smears of his blood. After bone marrow biopsy he was diagnosed with MDS with ...
متن کاملAcquired Elliptocytosis as a Manifestation of Myelodysplastic Syndrome Associated with Deletion of Chromosome 20q
Elliptocytosis is commonly seen as a hereditary condition. We present a case of myelodysplastic syndrome (MDS) del(q20) variant with concomitant acquired elliptocytosis. A 73-year-old male with a history of prostate cancer presented to the hospital for evaluation of bleeding gums. Initial evaluation showed Hgb of 9.3 gm/dl, hematocrit of 28%, platelet count of 36,000 K/cmm, and WBC of 1.8 K/cmm...
متن کاملAcquired Marked Elliptocytosis in Myelodysplastic Syndrome: Possible Association with Deletion (20q)
Myelodysplastic Syndromes (MDS) are heterogeneous group of myeloid malignancies that result in bone marrow failure and peripheral blood cytopenias. Elliptocytes are most abundant in hereditary elliptocytosis. Isolated deletion 20q [del (20q)] associated with elliptocytosis in a patient of myelodysplastic syndrome is very rare and only few cases are reported in literature. We report a case of 72...
متن کاملRange Determination of Antigen Expression in Myeloid, Erythroid and Lymphoid Cell Lineages among Patients with Myelodysplastic Syndrome
Background: Myelodysplastic syndrome is a mixed clonal disorder of bone marrow progenitor cells. Understanding the pattern of the different lineage-specific, immature, and mature markers in myelodysplastic syndrome will help in setting-up the frame of reference to diagnose. Patients and Methods: We compared 60 bone marrow samples from 30 newly-diagnosed patients with myelodysplastic syndrome ...
متن کاملMyeloid Cell Leukemia-1 Gene Expression and Clinicopathological Features in Myelodysplastic Syndrome
Background and Aims: Myeloid cell leukemia-1 (Mcl-1) plays a pivotal role in the survival of hematologic and solid tumors, and is known as a substantial oncogene. Studies have demonstrated the altered expression of Mcl-1 has been linked to malignancy development and poor prognosis. In this research, we have studied the expression of Mcl-1 mRNA in myelodysplastic syndrome (MDS) patients and det...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Blood
دوره 121 4 شماره
صفحات -
تاریخ انتشار 2013